A Detailed Analysis of the Legionella Testing Market Based on Stringent Regulatory Requirements for Water Quality Testing, Growing Concerns over Waterborne Diseases, and Increasing Awareness of Legionnaires' Disease Prevention
Report ID: PMRREP33962
Number of Pages: 217
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: January-2024
1. Executive Summary
1.1. Global Legionella Testing Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Test Type Lifecycle Analysis
2.4. Legionella Testing Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Legionella Testing Market Outlook: Test Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
3.3.3.1. Culture Media
3.3.3.2. Urine Antigen Testing
3.3.3.3. Direct Fluorescent Antibody
3.3.3.4. PCR
3.4. Market Attractiveness Analysis: Test Type
3.5. Global Legionella Testing Market Outlook: Application
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
3.5.3.1. Water Testing
3.5.3.2. IVD Testing
3.6. Market Attractiveness Analysis: Application
3.7. Global Legionella Testing Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
3.7.3.1. Hospitals and Clinics
3.7.3.2. Diagnostic Labs
3.7.3.3. Water Treatment Industries
3.8. Market Attractiveness Analysis: End User
4. Global Legionella Testing Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024 - 2031
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Test Type
5.3.3. By Application
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
5.5.1. Culture Media
5.5.2. Urine Antigen Testing
5.5.3. Direct Fluorescent Antibody
5.5.4. PCR
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
5.6.1. Water Testing
5.6.2. IVD Testing
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
5.7.1. Hospitals and Clinics
5.7.2. Diagnostic Labs
5.7.3. Water Treatment Industries
5.8. Market Attractiveness Analysis
6. Europe Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Test Type
6.3.3. By Application
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
6.5.1. Culture Media
6.5.2. Urine Antigen Testing
6.5.3. Direct Fluorescent Antibody
6.5.4. PCR
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
6.6.1. Water Testing
6.6.2. IVD Testing
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
6.7.1. Hospitals and Clinics
6.7.2. Diagnostic Labs
6.7.3. Water Treatment Industries
6.8. Market Attractiveness Analysis
7. East Asia Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Test Type
7.3.3. By Application
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
7.5.1. Culture Media
7.5.2. Urine Antigen Testing
7.5.3. Direct Fluorescent Antibody
7.5.4. PCR
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
7.6.1. Water Testing
7.6.2. IVD Testing
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
7.7.1. Hospitals and Clinics
7.7.2. Diagnostic Labs
7.7.3. Water Treatment Industries
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Test Type
8.3.3. By Application
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
8.5.1. Culture Media
8.5.2. Urine Antigen Testing
8.5.3. Direct Fluorescent Antibody
8.5.4. PCR
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
8.6.1. Water Testing
8.6.2. IVD Testing
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
8.7.1. Hospitals and Clinics
8.7.2. Diagnostic Labs
8.7.3. Water Treatment Industries
8.8. Market Attractiveness Analysis
9. Latin America Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Test Type
9.3.3. By Application
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
9.5.1. Culture Media
9.5.2. Urine Antigen Testing
9.5.3. Direct Fluorescent Antibody
9.5.4. PCR
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
9.6.1. Water Testing
9.6.2. IVD Testing
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
9.7.1. Hospitals and Clinics
9.7.2. Diagnostic Labs
9.7.3. Water Treatment Industries
9.8. Market Attractiveness Analysis
10. Middle East & Africa Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Application
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024 - 2031
10.5.1. Culture Media
10.5.2. Urine Antigen Testing
10.5.3. Direct Fluorescent Antibody
10.5.4. PCR
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
10.6.1. Water Testing
10.6.2. IVD Testing
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
10.7.1. Hospitals and Clinics
10.7.2. Diagnostic Labs
10.7.3. Water Treatment Industries
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Abbott
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Beckman Coulter, Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. BD
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bio-Rad Laboratories, Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. BIOMÉRIEUX
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Eiken Chemical Co., Ltd.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Hologic, Inc.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Pro Lab Diagnostics Inc.
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. QIAGEN
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. F. Hoffmann-La Roche Ltd.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Takara Bio Inc.
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Thermo Fisher Scientific Inc.
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
